Skip to content
★ Sign in to follow
HS

Harmel S. Rayat

Shareholder
RenovaCare, Inc.Phytomedical Technologies IncAlliqua BioMedical, Inc.International Energy, Inc.Octillion CorpCannabis Global, Inc.
Total declarations
53
Companies
6
▲ Purchases (4 ops.)
€2.6M
▼ Sales (7 ops.)
€458k

Latest filing published 03 Feb 2016 for RenovaCare, Inc., €918k.

Insider track record

Disclosed buys
4
Disclosed sells
7
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 03 Feb 2016 · 3931 days ago · €918k
    +102.5%
    Entry US$1.60 · Close at T+365 US$3.24

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Harmel S. Rayat: trading record in brief

Harmel S. Rayat has filed trades across 6 companies (mainly through SEC (Form 4)), most often in International Energy, Inc., RenovaCare, Inc. and Phytomedical Technologies Inc. In total, 53 filings cover trades dated from 15 March 2007 to 2 February 2016.

Both buying and selling appear: 4 purchases worth €2.6M, against 7 sales worth €458k. The net balance comes to €2.1M on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2016: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €749k.

On 3 February 2016 came the latest disclosure, an open-market purchase for €918k in RenovaCare, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Harmel S. Rayat

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations37 total

25 of 37 declarations